MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No.:

486638

Report Date :

30.01.2018

 

IDENTIFICATION DETAILS

 

Name :

SKITES PHARMA PRIVATE LIMITED

 

 

Registered Office :

Floor-G, 15, Mehta Mahal, P L Khandke Marg, Mathew Road, Opera House, Girgaon, Mumbai-400004, Maharashtra

Tel. No.:

91-22-66172500

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017 [SEVENTILAL KANTILAL & CO. – PARTNERSHIP CONCERN]

 

 

Date of Incorporation :

16.03.2017

 

 

Com. Reg. No.:

11-292537

 

 

Capital Investment / Paid-up Capital :

INR 0.100 Million [SKITES PHARMA PRIVATE LIMITED]

 

INR 59.767 Million [SEVENTILAL KANTILAL & CO. – PARTNERSHIP CONCERN]

 

 

CIN No.:

[Company Identification No.]

U24304MH2017PTC292537

 

 

IEC No.:

Not Divulged

 

 

GST No.:

27AAYCS3442F1ZY

 

 

TIN No.:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAYCS3442F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

·         Distributor of Pharmaceutical Products.  [Confirmed by Management]

 

·         Manufacturer, Formulate, Process and Marketing in all kinds of Pharmaceuticals, Antibiotics, Drugs, Medicines, Biologicals, Neutraceuticals, Healthcare, Ayurvedic, Dietary Supplement Products, Medicinal Preparations, Vaccines, Mixtures, Vitamins, Hormones, Herbals, Chemicals, Chemical Products, Dry Salters, Alkalies, Acids, Essences, Disinfectants, Fertilizers, Insecticides, Minerals, Petroleum Products, Oils, Foods, Toilataries, Surgical and Laboratory Equipments, Medicinal Preparations and to carry on the business of Bottling, Repacking, Processing of Tablets, Capsules, Syrups, Injections, Ointments etc. and to act as Chemists, Druggists, Buyers, Sellers, Agents, Consultants, Distributors and Stockists of all kinds of Pharmaceuticals and Allied Products. [Registered Activity]

 

 

No. of Employees :

40 (Approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 170700

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was established as a partnership concern in the year 1932 and later on 16 March 2017 it got converted in private limited company.

 

The subject is engaged as distributor of pharmaceutical products.

 

As per available financials of March 2017, the revenue has increased to 25.82% as compared to its previous year but has reported thin profit margin during the year.

 

Rating takes into consideration the satisfactory financial risk profile marked by adequate capital base and strong debt protection metric.

 

Rating continues to derive strength from its long and established track record of its business operations backed by the entrepreneurial experience of partners in pharmaceutical industry.

 

However, rating strengths are partially offset on account of absence of latest financial details and working capital intensive nature of operations in highly competitive pharmaceutical industry.

 

Payment seems to be usually correct.

 

In view of aforesaid, the subject can be considered for business dealings at usual trade terms and conditions.

 

NOTE 1:

The financials available are of “Partnership Concern”.

 

NOTE 2:

Site visit was conducted at the given address and our executive have successfully traced the subject.

 

Our executive met Mr. Pratik Thakkar (Authorized Person) provided with contact number (#09619309010).

 

As per our executive observation, it is a 7 storey building and the subject is situated on ground floor. The area of the premises is approximately 3340 SQ. FT.

 

Location is easy to find near “Railway Station” as landmark. Locality seems to be commercial and area near the premise building seems to be upmarket.

 

Further, our executive have sighted 10 employees at the premises and also sighted the name board of the subject on the given premise address.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.


 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 30.01.2018.

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION PARTED BY

 

Name :

Mr. Pratik Thakkar

Designation :

Authorised Person 

Contact No.:

91-9619309010

Date :

29.01.2018

 

 

LOCATIONS

 

Registered Office :

Floor-G, 15, Mehta Mahal, P L Khandke Marg, Mathew Road, Opera House, Girgaon, Mumbai-400004, Maharashtra, India

Tel. No.:

91-22-66172500

Mobile No.:

91-9619309010 [Mr. Pratik Thakkar]

Fax No.:

Not Available

E-Mail :

skitespharma@sk1932.com

skites@sk1932.com

Area :

3340 Sq. Ft.

Location :

Rented

Locality :

Commercial

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Samir Jayantilal Shah

Designation :

Director

Address :

3-B, Suvas Apartment, Rungta Lane, 68. F, Nepeansea Road, Mumbai-400006, Maharashtra, India

Date of Appointment :

16.03.2017

DIN No.:

00157396

Other Directorship :

CIN/FCRN

Company Name

Begin Date

End Date

L24230MH1960PLC011586

ANUH PHARMA LIMITED

23/09/2016

-

U24100MH2011PTC221911

ESKAY IODINE PRIVATE LIMITED

19/10/2011

-

U24230MH1990PTC057922

PRAGATI PHARMA PRIVATE LIMITED

29/08/1990

-

U24230MH1996PLC098246

S KANT HEALTHCARE LIMITED

06/06/2013

-

U24239MH1983PTC030195

S KANT PHARMA PRIVATE LIMITED

14/03/2007

-

U24239MH1983PTC030201

SEVANTILAL KANTILAL PRIVATE LIMITED

29/07/2008

-

U51102MH1983PTC029955

JAPOSHA TRADING PRIVATE LIMITED

22/07/1987

-

U74900MH2014PTC255450

BEETLE VENTURES PRIVATE LIMITED

30/05/2016

-

 

 

Name :

Mr. Rohan Mahesh Shah

Designation :

Director

Address :

Flat No.19, 3rd Floor, Prakash Bldg. No. 01 28 Ridge Road, Malabar Hill, Mumbai-400006, Maharashtra, India

Date of Appointment :

16.03.2017

DIN No.:

02867201

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24230MH1994PTC080562

S KANT CHEMICALS PRIVATE LIMITED

28/07/2010

 

 

KEY EXECUTIVES

 

Name :

Mr. Pratik Thakkar

Designation :

Authorised Person 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

No. of Shares

 

Percentage of Holding

Samir Jayantilal Shah

5000

50.00

Rohan Mahesh Shah

5000

50.00

 

 

 

Total

 

10000

100.00

 

 

 


 

BUSINESS DETAILS

 

Line of Business :

·         Distributor of Pharmaceutical Products.  [Confirmed by Management]

 

·         Manufacturer, Formulate, Process and Marketing in all kinds of Pharmaceuticals, Antibiotics, Drugs, Medicines, Biologicals, Neutraceuticals, Healthcare, Ayurvedic, Dietary Supplement Products, Medicinal Preparations, Vaccines, Mixtures, Vitamins, Hormones, Herbals, Chemicals, Chemical Products, Dry Salters, Alkalies, Acids, Essences, Disinfectants, Fertilizers, Insecticides, Minerals, Petroleum Products, Oils, Foods, Toilataries, Surgical and Laboratory Equipments, Medicinal Preparations and to carry on the business of Bottling, Repacking, Processing of Tablets, Capsules, Syrups, Injections, Ointments etc. and to act as Chemists, Druggists, Buyers, Sellers, Agents, Consultants, Distributors and Stockists of all kinds of Pharmaceuticals and Allied Products. [Registered Activity]

 

 

Products/ Services :

Pharmaceutical Products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

·         Lupin Limited

·         Sun Pharma Limited

·         Sanofi India Limited

·         Johnson and Johnson

·         Ranbaxy Laboratories Limited

 

 

Exports :

 

Products :

Not Available

Countries :

Not Available

 

 

Imports :

 

Products :

Not Available

Countries :

Not Available

 

 

Terms :

 

Selling :

Cheque

 

 

Purchasing :

Cheque

 

PRODUCTION STATUS: (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

Retailers and End Users

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

40 (Approximately)

 

 

Bankers :

 

Bank Name:

HDFC Bank Limited

Branch:

Sandoz House Branch, Worli, Mumbai, Maharashtra, India

Person Name (with Designation):

--

Contact Number:

91-22-61606161

Name of Account Holder:

SKITES PHARMA PRIVATE LIMITED

Account Number:

--

Account Since (Date/ Year of A/c Opening):

--

Average Balance Maintained (Optional):

--

Credit Facilities Enjoyed (CC/OD/Term Loan):

Current Account Only

Account Operation:

--

Remarks:

Ringing

 

 

Facilities :

[SEVENTILAL KANTILAL & CO. – PARTNERSHIP CONCERN]

 

SECURED LOANS

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

From HDFC Bank

 

 

Loan against Fixed Deposits

11.406

3.072

 

 

 

Total

 

11.406

3.072

 

 

 

Auditors :

 

Name :

P.O. Dharia and Company

Chartered Accountants

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates/Subsidiaries :

Not Available

 

 

CAPITAL STRUCTURE

 

SKITES PHARMA PRIVATE LIMITED

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

INR 10/- each

INR 0.100 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

INR 10/- each

INR 0.100 Million

 

 

 

 

 

SEVENTILAL KANTILAL & CO. – PARTNERSHIP CONCERN

 

AS ON: 31.03.2017

 

Name of the Partner

 

Balance as at 01-04-2016

Amount Introduced during the year

Interest for the year

Profit for the year

Withdrawals during the year

Balance as at 31-3-2017

Mahesh K. Shah

3.176

2.750

0.343

0.140

0.828

5.580

Samir J. Shah

55.716

29.200

4.120

0.384

36.217

53.208

Rohan M. Shah

2.881

6.800

0.149

0.140

8.990

0.979

 

 

 

 

 

 

 

Total

 

61.773

38.750

4.612

0.664

46.035

59.767

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

[SEVENTILAL KANTILAL & CO. - PARTNERSHIP CONCERN]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

SHAREHOLDERS FUNDS

 

 

 

1] Partners Capital Account

59.767

61.773

35.704

2] Reserves & Surplus

0.000

0.000

0.000

NETWORTH

59.767

61.773

35.704

LOAN FUNDS

 

 

 

1] Secured Loans

11.406

3.072

4.083

2] Unsecured Loans

46.641

37.603

12.597

TOTAL BORROWING

58.047

40.675

16.680

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

117.814

102.448

52.384

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

6.152

7.086

6.112

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

48.397
42.927

27.174

 

Sundry Debtors

62.451
56.682

21.806

 

Cash & Bank Balances

9.977
6.865

6.883

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

4.175
2.643

5.128

Total Current Assets

125.000
109.117

60.991

Less : CURRENT LIABILITIES & PROVISIONS

 
 
 

 

Sundry Creditors

 

 

Other Current Liabilities

11.988
12.905

12.304

 

Provisions

1.350
0.850

2.415

Total Current Liabilities

13.338
13.755

14.719

Net Current Assets

111.662
95.362

46.272

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

117.814

102.448

52.384

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Sales

680.795

541.043

322.364

 

 

Other Income

5.433

3.827

3.556

 

 

TOTAL                                    

686.228

544.870

325.920

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Goods Sold

654.329

514.953

305.987

 

 

Administrative, Selling and Other expenses

20.247

18.539

12.566

 

 

TOTAL                                    

674.576

533.492

318.553

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

11.652

11.378

7.367

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

9.212

6.887

4.988

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION              

2.440

4.491

2.379

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

1.273

1.332

1.181

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX                        

1.167

3.159

1.198

 

 

 

 

 

Less

TAX                                                                 

0.500

0.850

0.150

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX               

0.667

2.309

1.048

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Cash generated from operations

NA

NA

NA

 

 

 

 

Net Cash flow from (used in) Operations

NA

NA

NA

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

33.48

38.24

24.69

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

10.90

9.55

14.78

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.24

0.27

0.27

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

1.89

1.61

1.21

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.54

0.47

0.47

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.97

0.66

0.47

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

1.00

0.83

0.77

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.10

0.11

0.17

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

1.26

1.65

1.48

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

0.10

0.43

0.33

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

0.51

1.99

1.56

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

1.12

3.74

2.94

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

2.08

2.12

2.23

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.28

1.29

1.24

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.46

0.53

0.53

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.97

0.66

0.47

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

2.08

2.12

2.23

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 


 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

[SEVENTILAL KANTILAL & CO. - PARTNERSHIP CONCERN]

 

DEBT EQUITY RATIO

 

Particulars

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Partner’s Capital Account

35.704

61.773

59.767

Reserves & Surplus

0.000

0.000

0.000

Net worth

35.704

61.773

59.767

Secured Loans

4.083

3.072

11.406

Unsecured Loans

12.597

37.603

46.641

Total borrowings

16.680

40.675

58.047

Debt/Equity ratio

0.467

0.658

0.971

 

 

 


 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

322.364

541.043

680.795

 

 

67.836

25.830

 

 


 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

322.364

541.043

680.795

Profit

1.048

2.309

0.667

 

0.33%

0.43%

0.10%

 


LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

Yes

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

No

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

Yes

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years – Partnership Concern

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years – Partnership Concern

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 


 

OBSERVATION POINTS

 

Name of Company :

SKITES PHARMA PRIVATE LIMITED

 

 

Address :

Floor-G, 15, Mehta Mahal, P L Khandke Marg, Mathew Road, Opera House, Girgaon, Mumbai-400004, Maharashtra, India

Contact No.:

91-9619309010

 

 

Person to whom we met:

Mr. Pratik Thakkar (Authorised Person)

 

 

Name Board :

Sighted

 

 

Location:

Easy

 

 

Landmark (If Any):

Railway Station

 

 

Total Floors of the Building :

7 Floors

 

 

Subject situated on:

Ground Floor

 

 

Locality:

Commercial

 

 

Area of Premises :

3340 Sq. Ft.

 

 

Area :

Upmarket

 

 

No. of employees seen at premises:

10 (Approximately)

 

 

Visibility of Items:

·         Telephone

·         Computers

·         Air Conditioner

·         Office Equipment

·         Xerox Machine

 

 

Proof of visit:

Photos

 

 

INDEX OF CHARGES: NO CHARGES EXISTS FOR COMPANY

 

 

UNSECURED LOANS [SEVENTILAL KANTILAL & CO. – PARTNERSHIP CONCERN]

 

PARTICULARS

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

From Others

46.641

37.603

 

 

 

Total

 

46.641

37.603


FIXED ASSETS:

 

Tangible Assets

 

·         Buildings

·         Plant and Machinery

·         Air Conditioner

·         Computer

·         Furniture and Fixtures

·         Office Equipment

·         Electricity Installation

·         Fire Extinguishers

·         Telephone System

·         Computer Software

 

 

 

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.55

UK Pound

1

INR 89.82

Euro

1

INR 78.87

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

NIS

 

 

Report Prepared by :

IND

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.